{"id":"ece6ffb4-d0b1-50af-846b-26b0acf267b0","stable_key":"252872b9-233f-5692-b72b-c8930ba0cfb7:sil-improves-walking-and-pressure","predicate":"increases","statement":"In ten patients with pulmonary hypertension either primary or related to previous left-to-right shunts, thromboembolism or interstitial lung disease and poorly controlled on conventional therapy, sildenafil 25 milligrams eight hourly for two weeks was associated compared with placebo with improved exercise tolerance on the six-minute walk test at 266.67 against 170 metres, a decrease in modified Borg dyspnea score from 5.11 to 3.56, a decrease in Doppler-estimated pulmonary artery systolic pressure from 75.33 to 55.33 millimetres of mercury, and improvement in New York Heart Association class in two patients, with no significant changes in heart rate or blood pressure.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"68cb4044-b7e8-53b0-9aaf-1261604e3757","mechanism_event_label":"Two weeks of tablets let these patients walk nearly a hundred metres further and dropped the pressure in the lung.","subject":{"id":"fe62cf8d-5f89-5e19-bc36-03ad3c9063b7","slug":"sildenafil","display_name":"Sildenafil","entity_type_key":"drug"},"object":{"id":"c0eba152-bcc3-5e47-9d7d-b06f2ddcb105","slug":"six-minute-walk-distance","display_name":"Six-minute walk distance","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"68cb4044-b7e8-53b0-9aaf-1261604e3757","stable_key":"252872b9-233f-5692-b72b-c8930ba0cfb7:sil-improves-walking-and-pressure-event","event_type":"observed_intervention","label":"Two weeks of tablets let these patients walk nearly a hundred metres further and dropped the pressure in the lung.","description":"In ten patients with pulmonary hypertension either primary or related to previous left-to-right shunts, thromboembolism or interstitial lung disease and poorly controlled on conventional therapy, sildenafil 25 milligrams eight hourly for two weeks was associated compared with placebo with improved exercise tolerance on the six-minute walk test at 266.67 against 170 metres, a decrease in modified Borg dyspnea score from 5.11 to 3.56, a decrease in Doppler-estimated pulmonary artery systolic pressure from 75.33 to 55.33 millimetres of mercury, and improvement in New York Heart Association class in two patients, with no significant changes in heart rate or blood pressure.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"d0438bff-860f-5632-9428-e38802ba0df2","slug":"pulmonary-arterial-hypertension","display_name":"Pulmonary arterial hypertension","entity_type_key":"cellular_process"},"role":"treated_condition","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"47dc8e5a-5f3b-55d9-abbd-9b7f8b3e122c","slug":"pulmonary-artery-pressure","display_name":"Mean or systolic pulmonary artery pressure","entity_type_key":"cellular_process"},"role":"lowered_measure","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"d813f2a6-3ed1-54a7-84d2-d913bcda536f","slug":"exercise-capacity","display_name":"Exercise capacity","entity_type_key":"cellular_process"},"role":"improved_measure","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"736a4c55-284d-5361-bf7a-459544e16af1","slug":"systemic-blood-pressure","display_name":"Systemic arterial blood pressure","entity_type_key":"cellular_process"},"role":"unchanged_measure","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"5c2ca60f-0af2-5b25-b2ea-f75beda1f335","slug":"heart-rate","display_name":"Heart rate","entity_type_key":"cellular_process"},"role":"unchanged_measure","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"fe62cf8d-5f89-5e19-bc36-03ad3c9063b7","slug":"sildenafil","display_name":"Sildenafil","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"c0eba152-bcc3-5e47-9d7d-b06f2ddcb105","slug":"six-minute-walk-distance","display_name":"Six-minute walk distance","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/sildenafil-research/12760589.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"bca7bee4050068cd35e6f9f10a8de3c3a4505b4682eef9b8f91126ac1dbf38e5\", \"start_char\": 0, \"end_char\": 2507, \"text_sha256\": \"bca7bee4050068cd35e6f9f10a8de3c3a4505b4682eef9b8f91126ac1dbf38e5\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Randomised double-blind placebo-controlled crossover trial in ten consecutive patients poorly controlled on conventional therapy","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Sildenafil 25 milligrams every eight hours or matching placebo for two weeks each with a two-week run-in between","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Ten patients of mixed aetiology, with pulmonary artery pressure estimated by echo Doppler rather than catheter, and a two-week exposure.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6.","comparator":null,"unit":null,"notes":"","entity":{"slug":"sildenafil","display_name":"Sildenafil","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Two weeks of tablets let these patients walk nearly a hundred metres further and dropped the pressure in the lung.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[sil-p12760589] The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. (2003). https://pubmed.ncbi.nlm.nih.gov/12760589/","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Pulmonary circulation","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"51f81d80-0785-5d26-bb60-62feb0cdc437","evidence_kind":"source_excerpt","locator":"Lines 574-585","start_line":574,"end_line":585,"excerpt":"### sil-improves-walking-and-pressure\nIn ten patients with pulmonary hypertension either primary or related to previous left-to-right shunts, thromboembolism or interstitial lung disease and poorly controlled on conventional therapy, sildenafil 25 milligrams eight hourly for two weeks was associated compared with placebo with improved exercise tolerance on the six-minute walk test at 266.67 against 170 metres, a decrease in modified Borg dyspnea score from 5.11 to 3.56, a decrease in Doppler-estimated pulmonary artery systolic pressure from 75.33 to 55.33 millimetres of mercury, and improvement in New York Heart Association class in two patients, with no significant changes in heart rate or blood pressure.\nCondition category: normal\nnutrient_topic: Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6.\nplain_language: Two weeks of tablets let these patients walk nearly a hundred metres further and dropped the pressure in the lung.\norganism: Human\ntissue_or_cell_type: Pulmonary circulation\nexperimental_model: Randomised double-blind placebo-controlled crossover trial in ten consecutive patients poorly controlled on conventional therapy\nlimitations: Ten patients of mixed aetiology, with pulmonary artery pressure estimated by echo Doppler rather than catheter, and a two-week exposure.\nexposure: Sildenafil 25 milligrams every eight hours or matching placebo for two weeks each with a two-week run-in between\nevidence_span: {\"source_cache\": \"artifacts/sildenafil-research/12760589.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"bca7bee4050068cd35e6f9f10a8de3c3a4505b4682eef9b8f91126ac1dbf38e5\", \"start_char\": 0, \"end_char\": 2507, \"text_sha256\": \"bca7bee4050068cd35e6f9f10a8de3c3a4505b4682eef9b8f91126ac1dbf38e5\"}\n[sil-p12760589] The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. (2003). https://pubmed.ncbi.nlm.nih.gov/12760589/","model_system":"Randomised double-blind placebo-controlled crossover trial in ten consecutive patients poorly controlled on conventional therapy","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [sil-p12760589] The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. (2003). https://pubmed.ncbi.nlm.nih.gov/12760589/","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"c6c2a590-1f8f-5fac-b2c7-3aae0440b9fd","stable_key":"import-252872b9-233f-5692-b72b-c8930ba0cfb7","title":"Sildenafil: the enzyme it occupies instead of the substrate, why it cannot start a signal it can only preserve, the organic nitrate interaction that follows from that, the homologous retinal enzyme ten-fold away, and the pulmonary circulation where the same mechanism became a second indication (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"bc81793d20d20d2eaad9cb530b70695d8d8778a3d7136e24715ac3369b939953","revision_id":"301732e1-2446-5b67-b3bd-580164b85b05","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}